Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shyam_la
    Member
    • Mar 2012
    • 97

    #1

    Need help with CNV..

    Hi,

    I'm relatively new to bioinformatics. Have mastered SNVs and indels for the most part.. Now want to try my hand with CNVs.. I'm working with tumor-normal exome data..

    My question is, is it still possible to do CNV when my tumor and normal samples are sequenced to varying depths. Lets say the coverage on my tumor data is 90+ on average and on normal reads is 45+ on average. Is CNV still possible to be done? If so which tool should be used and what parameter should be altered?

    The analysis need not necessarily be paired. I just want to know which tumor samples have amplifications/deletions and in which regions/genes. I'm also interested in LoH in the tumor sample.

    Any help would be appreciated..
  • jujubix
    Member
    • May 2011
    • 14

    #2
    I briefly did some work determining CNV events in matched tumour/normal pairs, from my experience, the difference in coverage between libraries can be corrected for by normalizing the read counts.

    Some tools for determining CNV and LoH that worked for me include:

    HMMcopy for normalizing, identifying and classifying CNV events in matched and/or unmatched tumour samples:


    Apolloh, the accompanying software used to determine LoH events:


    Both were used to determing CNV and LOH events in a recent study here:

    Comment

    • shyam_la
      Member
      • Mar 2012
      • 97

      #3
      Thank you. They seem to be fairly complicated to use.. Will give them a shot..

      Originally posted by jujubix View Post
      I briefly did some work determining CNV events in matched tumour/normal pairs, from my experience, the difference in coverage between libraries can be corrected for by normalizing the read counts.

      Some tools for determining CNV and LoH that worked for me include:

      HMMcopy for normalizing, identifying and classifying CNV events in matched and/or unmatched tumour samples:


      Apolloh, the accompanying software used to determine LoH events:


      Both were used to determing CNV and LOH events in a recent study here:
      http://www.nature.com/nature/journal...ture10933.html

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:13 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Working...